146 related articles for article (PubMed ID: 10383790)
1. Pansclerotic morphea of childhood-follow-up over 6 years.
Wollina U; Looks A; Uhlemann C; Wollina K
Pediatr Dermatol; 1999; 16(3):245-7. PubMed ID: 10383790
[No Abstract] [Full Text] [Related]
2. Lipodermatosclerosis: successful treatment with danazol.
Hafner C; Wimmershoff M; Landthaler M; Vogt T
Acta Derm Venereol; 2005; 85(4):365-6. PubMed ID: 16191868
[No Abstract] [Full Text] [Related]
3. [Incapacitating pansclerotic morphea in childhood].
Ferrandiz C; Henkes J; González J; Peyri J
Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
[TBL] [Abstract][Full Text] [Related]
4. Pansclerotic morphea treated with UVA: a case report.
Yildirim M; Baysal V; Aridogan BC; Kesici D; Erturan I
J Dermatol; 2003 Aug; 30(8):625-7. PubMed ID: 12928533
[TBL] [Abstract][Full Text] [Related]
5. A Case of Pansclerotic Morphea Treated With Tocilizumab.
Zhang A; Nocton J; Chiu Y
JAMA Dermatol; 2019 Mar; 155(3):388-389. PubMed ID: 30649148
[No Abstract] [Full Text] [Related]
6. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
7. Disabling pansclerotic morphea of children.
Diaz-Perez JL; Connolly SM; Winkelmann RK
Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
[TBL] [Abstract][Full Text] [Related]
8. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
[TBL] [Abstract][Full Text] [Related]
9. Psoralen UVA therapy for linear and generalized morphea.
Morison WL
J Am Acad Dermatol; 1997 Oct; 37(4):657-9. PubMed ID: 9344214
[No Abstract] [Full Text] [Related]
10. Low-dose cyclosporine A in the treatment of disabling morphea.
Peter RU; Ruzicka T; Eckert F
Arch Dermatol; 1991 Sep; 127(9):1420-1. PubMed ID: 1892419
[No Abstract] [Full Text] [Related]
11. PUVA therapy in disabling pansclerotic morphoea of children.
Scharffetter-Kochanek K; Goldermann R; Lehmann P; Hölzle E; Goerz G
Br J Dermatol; 1995 May; 132(5):830-1. PubMed ID: 7772497
[No Abstract] [Full Text] [Related]
12. PUVA therapy for disabling pansclerotic morphoea of children.
Todd DJ; Askari A; Ektaish E
Br J Dermatol; 1998 Jan; 138(1):201-2. PubMed ID: 9536257
[No Abstract] [Full Text] [Related]
13. PUVA-cream photochemotherapy for the treatment of localized scleroderma.
Grundmann-Kollmann M; Ochsendorf F; Zollner TM; Spieth K; Sachsenberg-Studer E; Kaufmann R; Podda M
J Am Acad Dermatol; 2000 Oct; 43(4):675-8. PubMed ID: 11004625
[TBL] [Abstract][Full Text] [Related]
14. The discrepancy in hardness between clinical and histopathological findings in localized scleroderma treated with PUVA.
Yamaguchi K; Takeuchi I; Yoshii N; Gushi A; Kanekura T; Kanzaki T
J Dermatol; 1998 Aug; 25(8):544-6. PubMed ID: 9769602
[TBL] [Abstract][Full Text] [Related]
15. The "tank top sign": a unique pattern of skin fibrosis seen in pansclerotic morphea.
Sherber NS; Boin F; Hummers LK; Wigley FM
Ann Rheum Dis; 2009 Sep; 68(9):1511-2. PubMed ID: 19674989
[No Abstract] [Full Text] [Related]
16. Linear morphea overlying site of previous lichen aureus in a pediatric patient.
Johnston M; Benson P; Morley K
Pediatr Dermatol; 2019 Jul; 36(4):e91-e92. PubMed ID: 30994203
[TBL] [Abstract][Full Text] [Related]
17. Unilateral generalized morphea in childhood.
Nagai Y; Hattori T; Ishikawa O
J Dermatol; 2002 Jul; 29(7):435-8. PubMed ID: 12184643
[TBL] [Abstract][Full Text] [Related]
18. Linear scleroderma with severe leg deformity.
Hatzis JA; Stratigos AJ; Dimopoulos JC; Tzermias CK; Orfanidou A; Bassioukas KC
Australas J Dermatol; 1992; 33(3):155-7. PubMed ID: 1303076
[TBL] [Abstract][Full Text] [Related]
19. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association.
Devidayal ; Singh S; Kumar L; Radotra BD
Rheumatol Int; 2002 Jan; 21(4):158-60. PubMed ID: 11843172
[TBL] [Abstract][Full Text] [Related]
20. Hyperpigmentation of the basal layer [proceedings].
Freedman R
Arch Dermatol; 1977 Apr; 113(4):512. PubMed ID: 848986
[No Abstract] [Full Text] [Related]
[Next] [New Search]
